SEIZERT CAPITAL PARTNERS, LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 55 filers reported holding PSYCHEMEDICS CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SEIZERT CAPITAL PARTNERS, LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q1 2019$423,000
-11.7%
30,1790.0%0.02%
-13.6%
Q4 2018$479,000
-15.7%
30,1790.0%0.02%
+4.8%
Q3 2018$568,000
+14.7%
30,179
+30.3%
0.02%
+16.7%
Q2 2018$495,0000.0%23,1640.0%0.02%0.0%
Q1 2018$495,000
-31.7%
23,164
-34.3%
0.02%
-30.8%
Q4 2017$725,000
-3.5%
35,280
-13.4%
0.03%
-7.1%
Q3 2017$751,000
+1.5%
40,755
+37.3%
0.03%
+3.7%
Q2 2017$740,00029,6780.03%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 295,630$5,064,0003.16%
KELLEHER FINANCIAL ADVISORS 141,525$2,424,0001.32%
NAPLES GLOBAL ADVISORS, LLC 59,070$1,012,0000.62%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 164,106$2,811,0000.38%
North Star Investment Management Corp. 95,950$1,644,0000.34%
RBF Capital, LLC 78,495$1,345,0000.33%
New Jersey Better Educational Savings Trust 11,000$188,0000.09%
KENNEDY CAPITAL MANAGEMENT LLC 275,428$4,718,0000.09%
Hillsdale Investment Management Inc. 14,530$249,0000.07%
Granite Investment Partners, LLC 25,775$442,0000.07%
View complete list of PSYCHEMEDICS CORP shareholders